Spectral Medical Inc. (EDT) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Greetings. Welcome to Spectral Medical year-end 2025 corporate update and year-end review call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. Please note this conference is being recorded. I will now turn the conference over to Ali Mondavi, Capital Markets and Investor Relations. Thank you. You may begin. Thank you, Sherry. Good morning, everyone, and thanks for joining us for today's year-end corporate update call. Joining me this morning are Chris Seto, Chief Executive Officer of Spectral Medical, and Dr. John Kellen, Spectral's Chief Medical Officer. Following remarks from Chris and John, we will open the call for a Q&A session. Before we begin, we are required to provide the following statements regarding forward-looking information, which is made on behalf of Spectral Medical and all of its representatives on this call. The remarks and answers to your questions today may contain forward-looking information about future events or the company's future performance. This information is subject to risks and uncertainties that may cause actual events or results to differ materially. Any information regarding forward-looking statements is made as of today's date, and the company does not undertake to provide any forward-looking statements. I'll now turn the call over to Chris. Thank you, Ali, and good morning, everyone. This morning, Dr. Kellam and I are here to provide our year-end corporate update. Our intention is to give you a clear, structured view of where we stand today, the milestones immediately ahead of us, and how we are positioning Spectral for a successful 2026. S...